Evidence map›Paper›PMID 33343771›Full record

ArticlePharmacy practice

Mandatory pharmacist-led education session for patients seeking medical cannabis.

Vikas Parihar, Laura Katz, Mahmoud A Siyam, Anna Rogers, Lisa Patterson, Ramesh Zacharias

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmacy practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Pharmacist-Led Education in Psychiatry Residency Training.Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry · 2024
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Vikas PariharBSc(Pharm), PharmD. Michael G. DeGroote Pain Clinic, Hamilton Health Sciences, & Department of Anesthesia, McMaster University. Hamilton, ON (Canada). parihav@mcmaster.ca.ORCID https://orcid.org/0000-0002-3369-5908
Laura KatzPhD, CPsych. Michael G. DeGroote Pain Clinic, Hamilton Health Sciences, & Department of Psychology, Neuroscience and Behavior, McMaster University. Hamilton, ON (Canada). Laura.katz.121@gmail.com.ORCID https://orcid.org/0000-0003-2679-2862
Mahmoud A SiyamBSc. Michael G. DeGroote Pain Clinic, Hamilton Health Sciences, & School of Pharmacy, University of Waterloo. Waterloo, ON (Canada). siyammahmoud@gmail.com.ORCID https://orcid.org/0000-0003-1630-3922
Anna RogersBSc(Pharm). Michael G. DeGroote Pain Clinic, Hamilton Health Sciences. Hamilton, ON (Canada). roganna@hhsc.ca.ORCID https://orcid.org/0000-0002-1332-339X
Lisa PattersonBA. Michael G. DeGroote Pain Clinic, Hamilton Health Sciences. Hamilton, ON (Canada). Lisa.Patterson@niagarahealth.on.ca.ORCID https://orcid.org/0000-0002-4134-717X
Ramesh ZachariasMD, FRSC, DAAPM, CMD. Michael G. DeGroote Pain Clinic, Hamilton Health Sciences, & Department of Anesthesia, McMaster University. Hamilton, ON (Canada). zacharias@mcmaster.ca.ORCID https://orcid.org/0000-0003-4337-3416
Hamilton Health Sciences · CAUniversity of Waterloo · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe primary objectives of this pre-post session study, was to evaluate the impact of a pharmacist-led education session on the perceived benefits and safety of cannabis among patients with chronic pain, as well as determine the influence of pharmacist education on the selection of safer cannabis products and dosage forms for medical use among patients.

methodsA retrospective analysis of completed pre-post session questionnaires was conducted among chronic pain patients attending a mandatory education session led by a pharmacist, prior to being authorized cannabis in clinic. All questionnaire data was analyzed using SPSS v. 25. Demographic and sample characteristics were reviewed using univariate analyses. Chi-Square tests were employed to determine if the group-based education significantly affected knowledge, perception of efficacy and safety of cannabis.

resultsOf the 260 session participants, 203 completed pre-post session questionnaires. After the session, a majority of current cannabis users (33.8%) and cannabis naïve/past users (56.9%) reported they would use a low THC product in the future, and a majority of current users (54.5%) would use a high CBD product in the future. After education, participants were more likely to report cannabis as having the potential for addiction (chi-square =42.6, p <0.0001) and harm (chi-square =34.0, p <0.0001).

conclusionsPharmacist counselling and education has the potential to influence patient selection and use of cannabis, from more harmful to safer products, as well as moderate the potential perceived benefits of use.

Indexed as

CanadaCannabisChronic PainEducational MeasurementMedical MarijuanaPatient Education as TopicPatient PreferencePharmacistsSurveys and Questionnaires

Identifiers

PMID33343771
PMCPMC7732211
OpenAlexW3109859258

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.